REPL stock plunges after a second FDA CRL delays RP1 melanoma approval, casting doubt on its regulatory path and near-term growth plans.
The incident adds to security challenges in Balochistan, a flashpoint of insurgency where armed groups have frequently ...
The FDA grants priority review to Merck and Daiichi's BLA for ifinatamab deruxtecan to treat extensive-stage small cell lung ...
Three Pakistan Coast Guard personnel were killed in a brazen attack by Baloch militants on a patrol boat near the Iran border ...
A deadly attack on a Pakistan Coast Guard patrol boat near Gwadar has marked what appears to be the first sea-based strike by ...
Merck & Co (MSD) and Daiichi Sankyo have received priority review from the US Food and Drug Administration (FDA) for ...
The BLA Maritime Strike marks a new phase in attacks, expanding operations from land to sea. Discover the implications now.
In an unprecedented maritime attack, separatist insurgents killed three Pakistan Coast Guard personnel in the Arabian Sea.
India will establish an in-country depot facility for the F404-IN20 engines that power the Indian Air Force’s Light Combat ...
Daiichi Sankyo and Merck’s BLA for ifinatamab deruxtecan granted priority review in US for adult patients with ES-SCLC who experienced disease progression on or after platinum-b ...
QUETTA, Pakistan, April 12 (Reuters) - Separatist insurgents killed three Pakistan Coast Guard personnel on Sunday in the first-ever attack on one of the maritime authority's patrol boats operating in ...
Kirby McInerney LLP reminds Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ:ATRA) investors of the May 22, 2026 deadline to seek the role of lead plaintiff in a pending federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results